Life Science Company News

Berberine Could Treat Eczema-Exacerbated Staphylococcus aureus Infections

ATLANTA, June 16, 2024 /PRNewswire/ -- Eczema, a skin inflammatory disease that causes dry, itchy and inflamed skin, affects millions worldwide. Eczema is associated with an altered skin microbiome and higher colonization by Staphylococcus aureus. The study, led at New York Medical by postdoctoral fellow Anish R. Maskey, Ph.D., focuses on the natural compound berberine and its impact on eczema exacerbated by S. aureus. The findings, presented at ASM Microbe, shed light on berberine's ability to inhibit S. aureus colonization and alleviate eczema symptoms without adverse effects.

Current treatments often fall short— topical antibiotics can give temporary relief, but risk development of antibiotic resistance, and steroid use can potentially result in topical steroid withdrawal (TSW) syndrome. This study makes significant strides toward more effective eczema management using berberine.

The research team conducted comprehensive analyses, including whole genome sequencing of isolated S. aureus strains from eczema patients. The results revealed resistance genes and toxin-encoding genes, underscoring the urgency for alternative treatments. Berberine showed anti-inflammatory effects and inhibited mast cell degranulation, a key mechanism in eczema progression, suggesting its potential as a therapeutic agent. Mechanistic insights uncovered berberine's ability to suppress genes associated with inflammatory pathways, and computational modeling identified key targets in the PI3K/AKT pathways.

"Berberine may be a valuable natural product for treatment of multi-drug resistant S. aureus-exacerbated eczema due to its antibacterial and anti-inflammatory [effects] and inhibition of mast cell degranulation," Maskey said.

Funding from The Lie and Artati Family Fund and the Study of Integrative Medicine Fund supported this research.

ASM Microbe is the annual meeting of the American Society for Microbiology, held June 13-17, 2024, in Atlanta, Georgia.

The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 36,000 scientists and health practitioners. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications, educational opportunities and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

Cision View original content to download multimedia:

SOURCE American Society for Microbiology

By: PR Newswire Association LLC. - 16 Jun 2024
Back to overview

Enhance your business development with Biotechgate